3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Salivary Gland Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Hemangiosarcoma
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Breast Cancer
1
HER2-Positive Primary Breast Cancer
1
Glioma
1
Interventions
Azacitidine
10
Cyclophosphamide
9
venetoclax
7
fludarabine phosphate
7
fludarabine
6
Whole-Body Irradiation
6
Biopsy
6
Tacrolimus
5
Mycophenolic Acid
5
Injections
5
Decitabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Specimen Handling
4
Peripheral Blood Stem Cell Transplantation
4
Cytarabine
4
cedazuridine
3
Stem Cell Transplantation
3
Cyclosporine
3
X-Rays
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Ado-Trastuzumab Emtansine
×
90 days
×
Clear all
No trials found.